“An Unrelenting Disaster Zone”: Merck’s Alzheimer’s Drug Fails in Phase III Post author:Sam Post published:February 13, 2018 Post category:BioPharma Alzheimer’s drug development took another hit. Source: BioSpace You Might Also Like Bausch & Lomb Introduces Renu Advanced Formula Multi-Purpose Solution May 21, 2017 Vanda Pharmaceuticals’ Hetlioz Shows Promise for Treating Jet Lag March 4, 2018 <b>Gottlieb</b> Lays Out Plans to Attract and Preserve Top Talent at the FDA July 17, 2017
